EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tripartite Interplay of Epithelial, Immune, and Microbiota Dysregulation in Crohn's Disease: Mechanisms and Translational Strategies

Qing Lai iD, Qing-Yun Zhang iD, Wei-Peng Yang iD, Chun-Ying Luo iD

Immunity, Inflammation and Disease · 2026-10 · 14 (10)

DOI: 10.1002/iid3.70538 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 06.10.2026. Verfasst von Qing Lai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medicine Department, Youjiang Medical University for Nationalities, Baise, Guangxi, China. Hauptthemen laut MEDLINE: Crohn Disease, Intestinal Mucosa, Dysbiosis, Gastrointestinal Microbiome. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Natural Science Foundation Project, The Joint Special Plan Project of Regional Frequently Encountered Diseases of Baise City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Crohn's disease (CD) is a multifactorial inflammatory bowel disease (IBD) characterized by impaired epithelial barrier integrity, excessive immune hyperactivation, and gut microbiota perturbations. Cumulative evidence supports the role of the intestinal epithelial barrier, immune system and gut microbiota in the progression of CD.

Objective

This review constructs a mechanistic framework of the epithelial‐immune‐microbiota tripartite network in CD with a focus on positive‑feedback circuits sustaining persistent intestinal inflammation. Key Findings Interrelated pathological loops involving barrier injury, immune activation and microbial dysbiosis perpetuate chronic intestinal inflammation and provide a rationale for mechanism‑guided combinatorial therapeutic interventions.

Conclusions

This framework illuminates key pathogenic crosstalk that may be targeted to optimize future treatment regimens for CD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseIntestinal MucosaDysbiosisGastrointestinal MicrobiomeHumansAnimalsIntestinal Barrier Function

Stichwörter der Autor:innen

Crohn's diseaseepithelial barrier dysfunctiongut microbial dysbiosisimmune dysregulationprecision therapy

Autor:innen und Institutionen

  • Clinical Medicine Department, Youjiang Medical University for Nationalities, Baise, Guangxi, China.
  • Department of Pathology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.
  • Department of Science Research, The Fifth People's Hospital of Nanning, Nanning, Guangxi, China.

ORCID-Profile: Qing Lai, Qing-Yun Zhang, Wei-Peng Yang, Chun-Ying Luo

Förderung

  • Guangxi Natural Science Foundation Project
  • The Joint Special Plan Project of Regional Frequently Encountered Diseases of Baise City

Zitieren

APA

Lai, Q., Zhang, Q. Y., Yang, W. P., & Luo, C. Y. (2026). Tripartite Interplay of Epithelial, Immune, and Microbiota Dysregulation in Crohn's Disease: Mechanisms and Translational Strategies. Immunity, Inflammation and Disease, 14(10). https://doi.org/10.1002/iid3.70538

Vancouver

Lai Q, Zhang QY, Yang WP, Luo CY. Tripartite Interplay of Epithelial, Immune, and Microbiota Dysregulation in Crohn's Disease: Mechanisms and Translational Strategies. Immunity, Inflammation and Disease. 2026;14(10). doi:10.1002/iid3.70538

BibTeX
@article{Lai2026,
  author = {Lai, Qing and Zhang, Qing-Yun and Yang, Wei-Peng and Luo, Chun-Ying},
  title = {Tripartite Interplay of Epithelial, Immune, and Microbiota Dysregulation in Crohn's Disease: Mechanisms and Translational Strategies},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {10},
  doi = {10.1002/iid3.70538}
}
Kostenlos starten →